West Pharmaceutical Services | WST - Des Atouts





Des Atouts Changement Date
Align Technology USD 6.42B 103.41M 2026-06
Baxter International USD 19.79B 55M 2026-06
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Cerus USD 221.86M 6.67M 2025-12
Charles River Laboratories USD 7.53B 198.16M 2026-06
Cooper Companies USD 12.48B 58.1M 2026-03
Dentsply International USD 5.2B 25M 2026-06
Haemonetics USD 2.37B 30.52M 2026-06
ICU Medical USD 3.97B 42.48M 2026-06
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.56B 14.24M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
J&J USD 201.06B 167M 2026-06
Medtronic USD 93.03B 1.54B 2026-03
Merit Medical Systems USD 2.86B 144.34M 2026-06
Neogen USD 3.35B 13M 2026-03
OraSure Technologies USD 360.55M 18.62M 2026-06
Quidel USD 5.72B 86.6M 2026-06
Repligen USD 2.95B 19.41M 2026-06
Rockwell Medical USD 52.62M 1.34M 2025-06
Solventum Corp USD 14.24B 146M 2026-06
STAAR Surgical USD 475.2M 24.09M 2026-06
Terumo JPY 2.37T 61.86B 2026-06
Utah Medical Products USD 124.38M 1.84M 2026-03
West Pharmaceutical Services USD 4.08B 33.4M 2026-06